IGF2 and non-small cell lung carcinoma: Our research simulated the human NSCLC TME in vitro and in vivo and demonstrated that Trop2 functions as a key player in modulating IGF2-IGF1R-Akt axis signaling for drug resistance in NSCLC and TME remodeling in NSCLC.